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Members of the solute carrier family 25 (SLC25) are known to transport molecules over the mitochondrial membrane. In this paper we present
14 novel members of SLC25 family in human. These were provided with following gene symbols by the HGNC: SLC25A32, SLC25A33,
SLC25A34, SLC25A35, SLC25A37, SLC25A38, SLC25A39, SLC25A40, SLC25A41, SLC25A42, SLC25A43, SLC25A44, SLC25A45, and
SLC25A46. We also identified the orthologues for these genes in rat and mouse. Moreover, we found yeast orthologues for 9 of these genes and
show that the predicted substrate binding residues are highly conserved in the human and yeast proteins. We performed a comprehensive tissue
localization study for 9 of these genes on a panel of 30 rat tissues with quantitative real-time polymerse chain reaction. We detected their mRNA in
a wide number of tissues, both in brain and in periphery. This study provides an overall roadmap of the repertoire of the SLC25 family in
mammals, showing that there are at least 46 genes in the human genome coding for mitochondrial transporters.
© 2006 Elsevier Inc. All rights reserved.Keywords: Mitochondrial transporter; SLC; Human; Rat; Mouse; ExpressionGenes coding for membrane proteins comprise one of the
largest groups of genes in the vertebrate genome. Genes for
membrane proteins are claimed to constitute more than 10% of
all genes in the human [1] and mouse [2] genomes. Important
subgroups of membrane proteins are G-protein-coupled recep-
tors [3], single-pass tyrosine kinase receptors [4], ion channels
[5], and solute carriers [6]. Solute carriers control the uptake
and flow of various substances such as sugar, amino acids,
nucleotides, inorganic ions, and drugs over the cell membrane
and there are currently 43 known families of solute carriers
[6].
The solute carrier family 25 (SLC25) consists of proteins that
function as transporters of a large variety of molecules. This is a
family of structurally and functionally related proteins that
contain six α-helical membrane-spanning regions [7]. All of the
characterized SLC25s, with the exception of SLC25A17, which
is located in peroxisomal membrane [8], are localized to the
inner mitochondrial membrane [9] and are hence referred to as⁎ Corresponding author. Fax: +46 18 51 15 40.
E-mail address: robert.fredriksson@bmc.uu.se (R. Fredriksson).
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doi:10.1016/j.ygeno.2006.06.016mitochondrial carriers. In the most recent overview [9] 23
functionally known members of the SLC25 family were
presented, SLC25A1–SLC25A22 and SLC25A27. Since then,
an additional 9 proteins have been annotated from the various
human genome annotation projects and presented in the
Ensembl gene lists (http://www.ensembl.org).
The molecules transported by the SLC25 family of proteins
include ATP/ADP, amino acids (glutamate, aspartate, lysine,
histidine, and arginine), malate, ornithine, and citruline [9]. All
these molecules originate from macromolecules that constitute
the energy sources of cells and which are broken down into less
complex molecules by cellular enzymes. These metabolic inter-
mediates are transported into the mitochondria to be converted
into energy via oxidation, energy that is used to maintain the
proton gradient over the inner mitochondrial membrane. That
potential energy stored in this gradient is utilized to drive the
phosphorylation of ADP to produce ATP, the main form of
energy in the cell.
SLC25A7, SLC25A8, and SLC25A9, also known as
uncoupling proteins (UCP) 1, 2, and 3, have been shown to
transport protons directly [10] and these are among the most
well-studied members of the SLC25 family. They are referred to
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decoupling the electron transportation chains that exist across
the inner mitochondrial membrane and thereby enable energy
to be released as heat instead of being converted into ATP.
In addition to these “classical” UCP proteins, two others,
SLC25A27 (UCP4) and SLC25A14 (UCP5 or BMCP1), have
been discovered and these have been shown to mediate
mitochondrial uncoupling [11,12]. Several of the UCPs are
expressed in the central nervous system (CNS); for example,
SLC25A8 (UCP2) is highly expressed in the hypothalamus,
pituitary, and brainstem [13] but is also widely expressed in the
periphery [14]. SLC25A27 (UCP4) and SLC25A14 (UCP5 or
BMCP1) are, on the other hand, relatively selectively expressed
in the CNS [15]. BMCP1 has by in situ hybridization in mice
been shown to be highly expressed in hypothalamus, hippo-
campus, thalamus, and amygdala [12,16] while UCP4 is
broadly expressed in the brain [11]. These proteins have been
shown to be important in healthy neurons for energy
production and to have a role in neuronal signaling [17].
Mitochondrial UCPs have also been suggested to have a role
in neurodegenerative diseases such as Parkinson’s disease,
Alzheimer’s disease and ALS and in normal aging of the brain
[15]. Although the UCPs have been relatively extensively
studied in the CNS, the role of other SLC25 members in brain
is fairly unknown.
In this study we identified 14 novel genes that belong to the
SLC25 family. We performed phylogenetic analyses of these
genes in humans and rodents and discuss their relationship to
the previously known members of the family. We also per-
formed an extensive tissue localization study for 9 of these novel
genes in rat with the quantitative real-time PCR (qPCR)
technique and show that their mRNA is found in a wide number
of tissues, including several distinct brain regions. This study
shows that the SLC25 family has at least 46members in humans,
making it by far the largest of the 43 SLC families.Results
A dataset consisting of 29 SLC25 sequences, SLC25A1–
SLC25A29, was obtained by downloading all SLC25
sequences present in the SLC database at http://www.
bioparadigms.org/slc/menu.asp. This dataset was considered
the seeding set and from these sequences a sequence HMM
model was constructed. Four different databases, RefSeq,
Ensembl peptides, Ensembl AbInitio, and the human subset of
the Mammalian Gene Collection (MGC), were all searched
against that model and all hits were extracted. After filtration by
BLASTsearches against the human RefSeq database, removal of
possible pseudogenes, and manual curation, 17 sequences not
present in the seeding set remained. Three of these were found as
annotated sequences in the UCSC known gene track in the
UCSC genome database at http://genome.ucsc.edu/ as
SLC25A30, SLC25A31, and SLC25A36. The other 14 sequences
were considered novel and through communication with the
HUGO gene nomenclature committee the novelty of these
sequences was confirmed and new gene symbols wereallocated. Below we present the origin and database status of
each of these 14 sequences.
SLC25A32: This sequence was represented in GenBank by
four identical human mRNA sequences, BC021893, AK027787,
AF283645, and AK027531, which contain the complete coding
region. It was also represented by another mRNA sequence,
AK027531, which contains an alternative intron in the last exon.
The sequence was found to be supported by over 100 EST
sequences.
SLC25A33: The SLC25A33 sequence had seven (CR594441,
CR620898, CR593565, BC073135, AJ880283, BC004991, and
AF495714) full-length mRNAs supporting its entire coding
region. There was also one other sequence, CR595626, which
contained one extra, in-frame, exon between exons 2 and 3,
representing a possible splice variant. In addition this sequence
was found to be present as anMGC clone (number 4399) and was
supported by over 100 EST sequences.
SLC25A34: This sequence had one mRNA sequence,
BC027998, supporting its entire coding region and two partial
mRNA sequences, CR749264 and AL832282, supporting its
most C-terminal exon. In addition there were 11 ESTs sup-
porting this sequence.
SLC25A35: The SLC25A35 sequence had its entire coding
region supported by four mRNA sequences, AK097536,
BC041597, BC052233, and BC101329. In addition we found
two identical full-length mRNA sequences, BC101330 and
AY498866, with one additional in-frame exon between exons 4
and 5, which very likely represent functional splice variants of
the SLC25A35 sequence.
SLC25A37: The sequence version of SLC25A37 that we used
for our analysis was found to be supported by one mRNA se-
quence, which covers the entire coding region of SLC25A37. In
addition there are seven mRNAs (AK074708, AK223194,
AY032628, CR592142, BC015013, AK075313, and AL833186)
with alternative 5’ splice junctions for the second exon resulting in
a longer exon. None of these seems to be functional as elongation
of the second exon resulted in an interrupted open reading frame.
This, together with the fact that all seven sequences had different 5’
splice junctions suggests a weak splice signal. The SLC25A37
sequence was also supported by over 100 ESTsequences and over
20% of these ESTs supported the functional splice variant that we
used for our analysis.
SLC25A38: This sequence had six identical mRNA sequences
(AK000558, CR614324, CR619847, CR591050, BC013194,
and CR457242) supporting its entire coding region and two
partial mRNA sequences (CR621188 andAK026356) supporting
its two most C-terminal exons. In addition there were over 100
ESTs supporting this sequence.
SLC25A39: In total, this sequence was supported by 37
mRNAs that cover the entire coding region. The SLC25A39
sequence appeared to be present in two splice variants with an
alternative 3’ splice junction at the fourth exon resulting in an
eight-amino-acid-longer exon. Representative mRNAs for
the shorter variant are AF151827, AB209576, BC009330,
CR601587, and CR597204 while the longer variant was sup-
ported by, for example, BC096819, CR605651, CR594793,
CR610093, and CR605364. In total, the short and long variants
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to the mRNA sequences, the SLC25A39 was supported by over
100 ESTs.
SLC25A40: The SLC25A40 was included in the RefSeq
database as mitochondrial carrier functional protein (MCFP)
and its entire coding region is supported by five full-length
mRNAs (CR610506, BC027322, AK223020, AF125531, and
CR609204). In addition to the mRNA sequences, this sequence
was supported by 98 ESTs.
SLC25A41: This protein was supported by two mRNA
sequences, BC031671 and AK097761, and the latter of these
represents a functional splice variant with one extra in-frame
exon between exons 2 and 3. SLC25A41 is also present in the
MGC cDNA database as MGC34725. It is notable that all
sequences representing the human SLC25A41 are missing five
amino acids, including the first methionine in the first exon,
compared to orthologue sequences in rodents. There can be
two possible explanations for this: either there could be
another functional start codon further downstream in exon 1
or there is one additional exon upstream that contains the start
of the coding sequence. We consider the second alternative to
be the most likely as the amino acid sequence in exon 1,
except the five missing amino acids, is well conserved and
because no likely ribosomal entry sequence could be found in
exon 1. Therefore, the sequence presented in this paper is
partial. The sequence of SLC25A41 was supported by seven
ESTs.
SLC25A42: The SLC25A42 was present in the MGC as
MGC26694, which contains the entire coding sequence. Apart
from that, the sequence was supported by one full-length mRNA
(BC045598), which contains one extra in-frame exon between
exons 2 and 3. This is likely to represent a functional splice
variant. The sequence is also supported as being truly expressed
by 64 ESTs.
SLC25A43: The sequence for SLC25A43 is supported by
five mRNAs that cover the entire coding sequence. Two of
these (BC019584 and BC071871) are identical to the
sequence that we used for our analysis, while two other
(AK091304 and AX746905) support a functional splice
variant with one extra exons between exons 3 and 4 and the
fifth mRNA has one extra intron in exon 1. The sequence is
also supported by 35 ESTs.
SLC25A44: This sequence has five mRNA sequences
(AK074912, BC008843, AK075002, AB007915, and BC039854)
supporting its entire coding region. In addition to the mRNA
sequences we found over 100 ESTs supporting this sequence.
SLC25A45: The SLC25A45 protein was supported by six
mRNAs, which in total represents four functional splice
variants. The version used in this paper is represented by
BC041100. Compared to this sequence, one variant with an
extra exon between exons 2 and 3 is represented by mRNA
sequences BC036869 and CR591170. Another variant with the
same extra exon between exons 2 and 3, but also lacking the
third exon that is present in BC041100, is represented by
AY597807. The fourth variant was supported by two mRNA
sequences, AK091190 and AX746837. It is similar to the
second variant described, with the exception that it has one extraexon between exons 1 and 2 and the 3’ splice junction for exon
2 (i.e., the third exon for this variant) is further upstream in the
sequence resulting in a longer exon. The SLC25A45 sequence
was supported by 20 ESTs.
SLC25A46: The SLC45A46 was present in the RefSeq
database as LOC91137. Its coding region is supported by three
full-length mRNA sequences (AK091427, BC017169, and
M74089) and one partial mRNA (BX648087) that covers
the first three exons. The sequence was supported by over
100 ESTs.
We retrieved 14 rat and 14 mouse sequences from genome
databases and with a help of alignment and phylogenetic
analysis (data not shown) we confirmed that those were the
orthologues of our novel human SLC25 family members. All
the sequences that we assembled are included in the
supplementary material. Amino acid identity analysis is
presented in Supplementary Table 1. The percentage identity
within this family varies from 92% for the most similar pair of
sequences (SLC25A5 and SLC25A6) to 10% for the least
similar pair (SLC25A2 and SLC25A46). A phylogenetic tree
was constructed with all already known and novel human
SLC25 family members together with 10 yeast SLC25 family
proteins. This tree is presented in Fig. 1. The novel human
sequences were spread through the tree and most of them
display paralogous relationships to previously reported SLC25
proteins.
We performed an expression analysis of rat UCP2 and nine
of the novel rat SLC25 family members in a range of tissues.
Eight coronal sections of rat brain (Fig. 2), hypothalamus,
brainstem, hindbrain (cerebellum, pons, and medulla oblon-
gata), pituitary gland, cerebellum, spinal cord, pineal gland,
eye, adrenal gland, skeletal muscle, adipose tissue, heart,
intestine, kidney, liver, lung, spleen, thymus, ovary, uterus,
testis, and epididymis were isolated and used for RNA
isolation and cDNA synthesis. Two housekeeping genes
histone 3 (H3) and ribosomal protein L19 (RPL19) were
used to calculate normalization factors. The gene expression
stability measures were 0.662 and 0.646 for H3 and RPL19,
respectively. The relative expression values (%±SD%) for
UCP2, Slc25a32, Slc25a37, and Slc25a40-46 are presented
on Fig. 3 and in Supplementary Table 2. The relative
expression of UCP2 was highest in the pituitary gland, kidney,
heart, and adrenal gland. We were not able to detect the
transcript in the brain coronal sections I and II. The highest
levels of Slc25a33 were detected in the brainstem, coronal
section VIII, coronal section IV, and pineal gland. The
expression levels of Slc25a37 were highest in brain sections
II and I, testis, and liver. We did not find the Slc25a37
transcript in hypothalamus, pineal gland, intestine, and
epididymis. The highest levels of Slc25a40 were detected in
coronal section I, coronal section II, cerebellum, and coronal
section VII. The transcript for Slc25A41 was detected only in
coronal sections I to VII, liver, and testis and at very low level
in epididymis. The highest expression was in coronal sections
I and II. Slc25a42 had very high transcript levels in adipose
tissue. The next highest levels were detected in brain section
VII, hypothalamus, and section IV. Slc25a43 was detected at
Fig. 1. Phylogenetic analysis of full-length amino acid sequences of human SLC25A1-46 and 10 yeast SLC25 family members. The consensus tree was generated by
Neighbor-Joining analysis (Phylip 3.6). The numbers at the nodes indicate bootstrap replicates. The novel sequences are underlined. The preferred substrate, if known,
is stated after the slash. The accession numbers are listed under Materials and methods.
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and skeletal muscle. The relative expression of Slc25a44 was
highest in hindbrain, brain sections IV and VII, and
cerebellum. Levels of Slc25a45 were highest in coronal
section I, skeletal muscle, intestine, and coronal section II. The
transcripts for neither Slc25a43 nor Slc25a45 were detected in
hypothalamus. The expression of Slc25a46 was detected as
highest in hindbrain, coronal section IV, spinal cord, and
section VII.
In general, the UCP2, Slc25a42, and Slc25a46 had the
highest expression levels of all the SLC25 family memberstested in this study. Overall, the expression was lowest for
Slc25a37 and Slc25a40 in all tested tissues.
Discussion
We have identified 14 new human members of the solute
carrier family 25 (SLC25). We also identified their orthologues
in mouse and rat. The new transporters were approved by the
HUGO gene nomenclature committee and were given the gene
symbols SLC25A32–A35 and SLC25A37–SLC25A46 (Table 1).
Taking into consideration the amount of genomic data, ESTs,
Fig. 2. Schematic presentation of rat brain coronal sections. The sections are marked with Roman numerals.
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unlikely that there exist additional members of the SLC25 family
in humans. We therefore conclude that the repertoire of the
SLC25 family is fairly complete with 46 members in humans
and 45 members in mice and rats. This makes the SLC25 family
the largest of the 43 SLC families.
All the novel solute carriers exhibit the common features
characteristic for the SLC25 family, such as complex genomic
structure with a large number of exons. They also have a similar
secondary structure with six predicted transmembrane helices.
We have performed amino acid identity analysis (Supplemen-
tary Table 1) and constructed a phylogenetic tree for all known
human SLC25 proteins together with 10 yeast proteins from the
same family [22] (Fig. 1). The expression of all novel solute
carriers is supported by EST data and we present quantitative
real-time PCR data for nine of them. Together the results
indicate that all of the 14 sequences belong to the SLC25 family
and are most likely functional proteins. Our phylogenetic
analysis is consistent with previously published trees [9] and
shows a clear clustering of carriers transporting the same
substrate (Fig. 1). It has been previously shown for solute
carrier family 6 (SLC6) that phylogenetically related proteins
have the same or similar substrates [28]. Therefore we were
encouraged to speculate about the possible substrate preference
and functional properties of newly identified SLC25 family
members.
SLC25A34 and SLC25A35 display 45% amino acid
identity to each other and branched basal of the UCP/DIC/
OGC cluster in the phylogenetic tree. The similarity is
further supported by local blast search, which simultaneously
displays SLC25A11 as the closest relative with 26–33%
amino acid identity. SLC25A35, SLC25A11, and SLC25A10
are all located on human chromosome 17 (see Fig. 4), which
might indicate a common origin. Interestingly, the phylogenetic
analysis revealed that SLC25A34 and SLC25A35 are
orthologues to the yeast oxaloacetate carrier, YKL120w [29],
and have 35 and 29% amino acid identity to this protein. It is
therefore possible that these human solute carriers have asubstrate similar to the substrate of the yeast oxaloacetate
carrier.
To show the reliability of our real-time assay, we performed
expressional analysis for Slc25a8, known as UCP2. UCP2
showed the highest expression in pituitary, which is in very
good agreement with the previously published data, where
mRNA for UCP2 from monkey was detected in anterior
pituitary with in situ hybridization [30]. We also show that
UCP2 is widely distributed in the periphery as previously
described including the female reproductive system in rat that
has been reported before in mouse [31].
In addition to the UCPs the ADP/ATP carriers are the
second most studied members of the SLC25 family. ATP is an
energy source for every living cell and a common substrate for
SLC25 family proteins. The fourth isoform of the ADP/ATP
carriers, named AAC4 (SLC25A31), has recently been
reported [32]. There are three known isoforms of ATP-Mg
transporters, named SLC25A23, 24, and 25, and here we have
probably identified the fourth isoform, SLC25A41. This gene
and Slc25a23 are located on the same chromosome in human
(h19), mouse (m17), and rat (r27) and they are positioned in
close proximity to each other. The distances between these
two genes are around 10, 6 and 3 kb in human, mouse, and
rat, respectively (see Fig. 4). Considering the complex
genomic structure of solute carrier genes, this distance is
quite small and probably indicates the common origin and
perhaps a functional pressure for their close proximity in the
genome, such as a common transcriptional regulation. The
predicted protein sequence of SLC25A41 grouped phylogen-
etically with SLC25A23 at the top of ATP-Mg carrier cluster.
The SLC25A41 branched with a bootstrap value of 747, while
the whole cluster branched from other SLC25 members with a
highly convincing bootstrap value of 997. The predicted
SLC25A41 protein shares 54–64% amino acid identity with
ATP-Mg carriers. A crystal structure of the bovine ATP/ADP
carrier has been described [7] and based on this model the
substrate binding site for different SLC25 proteins was
recently modeled, describing all possible substrate contact
Fig. 3. Relative expression of rat mRNA for nine novel SLC25 carriers and UCP2. The coronal sections are marked with Roman numerals. Hindbrain includes
cerebellum, pons, and medulla oblongata. Error bars indicate standard deviation.
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Table 1
Information about novel members of SLC25 family in human, mouse, and rat
Name Protein length (AA) Number of exons Chromosomal position AA identity (%) for closest human
relative with Blast search
Human relative with highest
AA identity (%)
SLC25A32 (human) 295 7 Chr 8 (104481817) SLC25A36 (30%) SLC25A36 (30%)
Slc25a32 (mouse) 316 7 Chr 15 (38995602)
Slc25a32 (rat) 316 7 Chr 7 (74651731)
SLC25A33 (human) 315 7 Chr 1 (9534016) SLC25A36 (61%) SLC25A36 (61%)
Slc25a33 (mouse) 320 7 Chr 4 (148237103)
Slc25a33 (rat) 320 7 Chr 5 (166836889)




Slc25a34 (mouse) 302 5 Chr 4 (140501676)
Slc25a34 (rat) 302 5 Chr 5 (160520108)




Slc25a35 (mouse) 300 5 Chr 11 (68694321)
Slc25a35 (rat) 300 5 Chr 10 (55727781)
SLC25A37 (human) 351 5 Chr 8 (23442460) SLC25A28 (58%) SLC25A28 (58%)
Slc25a37 (mouse) 338 4 Chr 14 (63778410)
Slc25a37 (rat) 338 4 Chr 15 (49806744)
SLC25A38 (human) 303 7 Chr 3 (39400219) SLC25A1 (23%) SLC25A30 (27%)
Slc25a38 (mouse) 326 7 Chr 9 (120120397)
Slc25A38 (rat) 326 7 Chr 8 (125084567)




Slc25a39 (mouse) 359 11 Chr 11 (102224510)
Slc25a39 (rat) 359 11 Chr 10 (91511138)




Slc25a40 (mouse) 337 10 Chr 5 (8434063)
Slc25a40 rat 337 7 Chr 4 (21497685)
SLC25A41 (human) a 314 6 Chr 19 (6377402) SLC25A23 (64%) SLC25A23 (64%)
Slc25a41 (mouse) 312 6 Chr 17 (54722926)
Slc25a41 (rat) 319 6 Chr 3 (11541050)
SLC25A42 (human) 418 7 Chr 19 (19067933) SLC25A16 (36%) SLC25A16 (36%)
Slc25a42 (mouse) 318 7 Chr 8 (69339447)
Slc25a42 (rat) 318 7 Chr 16 (19711606)
SLC25A43 (human) 335 5 Chr X (118315248) SLC25A16 (29%) SLC25A16, A41 (29%)
Slc25a43 (mouse) 341 5 Chr X (31364298)
Slc25a43 (rat) 329 5 Chr X (8096172)
SLC25A44 (human) 321 3 Chr 1 (152982711) SLC25A13 (26%) SLC25A12 (28%)
Slc25a44 (mouse) 314 3 Chr 3 (88156573)
Slc25a44 (rat) 314 3 Chr 2 (180514440)
SLC25A45 (human) 304 7 Chr 11 (64900243) SLC25A29 (25%) SLC25A29 (25%)
Slc25a45 (mouse) 288 6 Chr 19 (5667445)
Slc25a45 (rat) 276 5 Chr 1 (208514958)
SLC25A46 (human) 347 8 Chr 5 (110102719) SLC25A19 (14%) SLC25A8 (17%)
Slc25a46 (mouse) 418 8 Chr 8 (31822955)
Slc25a46 (rat) 418 8 Chr 18 (23991190)
a Missing first exon, five amino acids.
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SLC25A23-25, Sal1p, binds ATP-Mg to the R242, K314,
E318, G416, and I417, which are conserved in human ATP-
Mg carriers. Interestingly, the SLC25A41 has all contact
points, R40, K91, E95, G184, and I185, identical to the other
ATP-Mg carriers. The expression profile of Slc25a41 is
similar to that of SLC25A23 (APC2), which also has in
general low mRNA levels [34]. The transcripts of SLC25A23
and SLC25A25 (APC3), but not SLC25A24 (APC1), were
previously detected in human brain tissue. The presence of
Slc25a41 mRNA in seven coronal rat brain sections, but not
in brainstem, hypothalamus, or hindbrain, probably indicates acortical expression pattern. Abundance of mRNA in CNS
combined with the presence of mRNA only in two peripheral
tissues might suggest a more important central function. This
altogether further supports our inference that SLC25A41
might be a novel fourth isoform of ATP-Mg carrier.
The ATP-Mg cluster grouped with SLC25A16 or the so
called Grave’s Disease carrier (Fig. 1). SLC25A16 is thought to
be responsible for transport of CoA into mitochondria [35].
Interestingly, one of the novel solute carriers, SLC25A42,
shares 36% amino acid identity with SLC25A16 and they are
grouped with a high bootstrap value of 961. Another novel
carrier, SLC25A43, also has SLC25A16 as its closest relative
Fig. 4. Schematic presentation of chromosomal synteny for SLC25 family genes; h, human; m, mouse; r, rat. The chromosome number is next to the species. Arrowed
boxes indicate the direction of the ORF. Inside each box, the Arabic numeral is the SLC25A number, while the Roman numeral denotes the number of exons.
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expression levels than Slc25a43. The presence of mRNA for
Slc25a42 in all brain regions of rat, including high levels in
the hypothalamus and brainstem, possibly suggests an impor-
tant basal physiological function. Similarly to SLC25A16 [36],
Slc25a42 and Slc25a43 displayed wide peripheral distribution.Interestingly, Slc25a42 transcript levels in male and female
reproductive system, spleen, and thymus of rat were much
lower than in other tested tissues. When we compared the
proposed substrate binding points for SLC25A16, its yeast
orthologue Leu5, and SLC25A42-43, we found small differ-
ences but surprisingly, another yeast solute carrier, YPR011c,
787T. Haitina et al. / Genomics 88 (2006) 779–790displayed binding points identical with those of SLC25A42,
which might indicate the common substrate. We found that
SLC25A42 shares 32% identity with YPR011c.
We have also identified the sequence SLC25A32, which
shows 30% amino acid identity to SLC25A36 and displays
orthologue relationships to three yeast solute carriers,
YEL006w, YIL006w, and Flx1p. The first two, recently repor-
ted as NAD+ transporters [37], displayed higher identity (33%)
to the SLC25A32 than the third one, shown to function as a
FAD transporter (30% identity) [38]. It was suggested by
Palmieri [9] that there are SLC25 proteins in human with
important transport functions, orthologues to those functionally
characterized in yeast. Still, taking this suggestion into
consideration, it is surprising how highly conserved the
SLC25 proteins are in human and yeast. We compared substrate
binding points and found that they are almost identical:
W88/96/153, Y91/99/156, G193/192/246, V194/T193/L247,
and K237/235/289 for Flx1p/SLC25A32/YIL06w, respec-
tively. Therefore it is likely that SLC25A32 has a FAD/
NAD-like substrate.
We have identified the sequence named SLC25A45, which in
phylogenetic analysis, blast, and amino acid analysis showed that
the closest human relative was SLC25A29 (CACL). SLC25A29
together with SLC25A20 (CACT) are known to be responsible for
transport of long-chain fatty acids [9]. SLC25A29 transports
palmitoylcarnitine [39], while SLC25A20 transports acylcarnitine
and it has been suggested that they work cooperatively [39].
Similarly to SLC25A29, Slc25a45 mRNA was detected in the
brain. Like SLC25A29 and SLC25A20, Slc25a45 displayed wide
peripheral distribution. Knowing that SLC25A20 and possibly
SLC25A29 deficiency is life threatening [40], it would be very
intriguing to investigate the function of SLC25A45.
Some of the most recently identified human solute carriers are
SLC25A30 and SLC25A36. The former was identified as renal
uncoupling protein [41], while the function of SLC25A36 is still
unknown. Surprisingly, we identified a homologous sequence
with 61% amino acid identity to SLC25A36, named SLC25A33.
Once again we identified the orthologue of these two sequences
in yeast, YBR192w, described as pyrimidine nucleotide trans-
porter [42]. We detected the highest levels of Slc25a33 in the
CNS, particularly in the brainstem. The mRNA levels of
Slc25a33 in peripheral tissues were very low, suggesting that the
primary function is in CNS. SLC25A44 and SLC25A46 are two
other novel solute carriers with higher expression levels in CNS
than in periphery. These two solute carriers and SLC25A38 are
quite different from other human SLC25 family members and
from each other. But according to phylogenetic analysis
SLC25A38 seems to have an orthologue in yeast, YDL119c.
They share 33% amino acid identity and have the same residues
in the substrate binding pocket.
We have identified SLC25A37 which has highest amino acid
identity to human SLC25A28 and yeast MRS3p and MRS4p. It
has been shown that MRS3/4p transport iron [43]. The identity
of the substrate binding amino acids implies that iron is a
possible substrate for SLC25A37. We detected mRNA for
Slc25a37 in a number of tissues, including brain and peripheral
organs but at low levels. The high levels of Slc25a37 weredetected in blood (data not shown). During preparation of this
article, a study presenting SLC25A37, named mitoferrin, was
published [44]. This study demonstrates the essential function of
SLC25A37 in zebrafish and mouse as an iron transporter.
It has been previously shown that yeast solute carrier MTM1
(YGR257c) is responsible for activation of manganese-contain-
ing superoxide dismutase [45]. We have identified two proteins
that possibly can perform this important function in human. We
found two novel solute carriers SLC25A39 and SLC25A40,
which are the orthologues of yeast MTM1. These human pro-
teins share 52% identity with each other and 32–35% identity
with MTM1. The mRNA for Slc25a40was widely distributed in
many tissues but at low levels. We discovered that amino acid
residues in the substrate binding pocket are identical in these
three proteins and these are M131/125/113, A135/129/117,
Y139/133/121, R232/217/205, D233/218/206, and K341/321/
309 for YGR257c/SLC25A39/SLC25A40, respectively. It is
therefore possible that we have identified two novel solute
carriers, which could be responsible for activation of manga-
nese-containing superoxide dismutase in human.
In summary we have identified the genes coding for 14
novel human transporters from the SLC25 family of
mitochondrial carriers. We present detailed expression charts
for 9 of these in rat. We provide a roadmap for the entire
repertoire in human, mouse, and rat. Moreover, we identified
orthologues for these proteins in yeast and show that the
residues providing the contact points for the substrate are, in
several cases, completely conserved in the human and yeast
proteins.Material and methods
Construction of hidden Markov models
The sequences for all known SLC25 family of proteins were downloaded
from theNCBIWWWpage using the Entrez data retrieval tool (http://www.ncbi.
nlm.nih.gov/) based on the accession numbers obtained from the SLC database
(http://www.bioparadigms.org/slc/menu.asp). This resulted in a dataset with 29
sequences with the following accession numbers: SLC25A1, gi|14165517;
SLC25A2, gi|13994341; SLC25A3, gi|6031192; SLC25A4, gi|38181966;
SLC25A5, gi|4502099; SLC25A6, gi|15928608; SLC25A7, gi|68532581;
SLC25A8, gi|67515419; SLC25A9, gi|4507807; SLC25A10, gi|20149598;
SLC25A11, gi|23844; SLC25A12, gi|21361103; SLC25A13, gi|7657581;
SLC25A14, gi|4507009; SLC25A15, gi|7657585; SLC25A16, gi|27544933;
SLC25A17, gi|5453918; SLC25A18, gi|47678687; SLC25A19, gi|31543632;
SLC25A20, gi|54695946; SLC25A21, gi|75517681; SLC25A22, gi|23273778;
SLC25A23, gi|48476342; SLC25A24, gi|33598954; SLC25A25, gi|56699401;
SLC25A26, gi|31455201; SLC25A27, gi|55665525; SLC25A28, gi|28703800;
SLC25A29, gi|47077783. The receptor sequences were subsequently aligned
using ClustalW 1.83 [18] using default settings. From the alignments, Profile
Hidden Markov Models (HMMs) were constructed using the HMMER 2.2
package [19]. The models were constructed using HMMbuild with default
settings and calibrated using HMMcalibrate.
Construction of a reference database
A reference database was constructed from the RefSeq dataset version 35
(May 2005 release) (ftp://ftp.ncbi.nih.gov/ refseq/H_sapiens/) by first removing
all SLC proteins that were present in the SLC database (http://www.
bioparadigms.org/slc/menu.asp), in total 307 SLC proteins, from the RefSeq
datafile using repeated BLASTP searches. The sequence names of all 307 SLC
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identification. The RefSeq file that was lacking all SLC sequences was then
merged with the modified SLC database into a Fasta file containing 29,061
proteins. A protein database was finally constructed from this Fasta file using
formatdb from the version 2.2.6 BLAST package [20].
Identification of novel members of the SLC25 family
Fasta files containing the protein versions of the human RefSeq database
version 35 (May 2005 release) (ftp://ftp.ncbi.nih.gov/ refseq/H_sapiens/), the
Ensembl human peptide database version 35 (April 2005 release) (ftp://ftp.
ensembl.org/pub/current_homo_sapiens/data/fasta/pep/), the human Mamma-
lian Gene Collection (MGC) cDNA database (Downloaded 6th of June 2005)
(ftp://ftp1.nci.nih.gov/pub/MGC/fasta/), and the Ensembl human AbInitio
protein database version 35 (April 2005 release) (ftp://ftp.ensembl.org/pub/
current_homo_sapiens/data/fasta/pep/) were downloaded. The MGC database
was available only as cDNA sequences and these were batch-translated into
protein using a custom made JAVA program (available upon request). These
protein Fasta files were searched, one database at a time in the order given
above, against the HMM model using HMMsearch from the HMMER 2.2
package with a cutoff at E=10. The sequences for all hits were extracted using
bash-scripts and a custom made JAVA program (available upon request) and
searched against the reference database using BLASTP. The three best BLAST
hits were considered and at least one of these had to be a SLC25 for that
sequence to be further considered. To remove the previously known sequences
all hits were aligned against the human genome using translated BLAT. The
resulting PSL files were parsed, the BLAT scores were calculated according to
[21] and only the highest scoring position was kept. This was done using a
custom made JAVA program (available upon request). Finally, the sequences
from the HMM search were aligned against the genome and all sequences that
aligned to the same position in the genome as one of the previously known SLC
sequences were removed using a JAVA program (available upon request). The
novel hits were then merged into the set of known SLC25 proteins and the
procedure was repeated for the next dataset. The order in which the datasets were
used (RefSeq, Ensembl peptide, MGC, Ensembl AbInitio) ensured that the
sequence most likely to be of high quality was used.
The new human sequences were searched against mouse and rat genomes
using BLAT (amino acid sequence against genome) at (http://genome.ucsc.
edu/). All the identified rat and mouse cDNA sequences were retrieved from
the database and aligned with the human sequences.
Phylogenetic analysis
The human SLC25 sequences were combined with the sequences of 10
related transporters from yeast [22] into one Fasta file and aligned using the
UNIX version of ClustalW 1.83. The default alignment parameters were
applied. The sequences were then realigned and bootstrapped 1000 times using
SEQBOOT from the Win32 version of the Phylip 3.6 package [23]. Protein
distances were calculated using PROTDIST from Phylip 3.6. The Jones–
Taylor–Thornton matrix was used for the calculation. The Neighbor-Joining
trees were calculated from the 1000 different distance matrixes, previously
generated with PROTDIST, using NEIGHBOR from Phylip 3.6 a3. Majority
rule consensus trees were constructed with CONSENSE from theWin32 version
of the Phylip 3.5 package. The trees were plotted using TreeView [24].
Animal handling and tissue isolation
Four male and two female Sprague–Dawley rats (Alab, Sweden) were kept
in air-conditioned rooms (12 h dark/light cycle) at 22–23°C in an air humidity
of 55%. The rats had free access to water and R36 food pellets (Labfor,
Lactamin, Sweden). These conditions were maintained for 7 days, and at the end
of the period the animals were sacrificed by decapitation between 3 and 6 h into
the light period. Different brain regions and peripheral tissues were isolated.
Two whole brains were dissected into coronal sections using a brain matrix
(Pelco International, Canada) as presented in Fig. 2. The tissues were immersed
into RNA-later solution (Ambion, USA), kept at room temperature for 1 h and
thereafter stored at –80°C until further processed.RNA isolation and cDNA synthesis
Individual tissue samples were homogenized by sonication in TRIzol
reagent (Invitrogen, Sweden) using a Branson sonifier. Chloroform was added
to the homogenate, which was then centrifuged at 10,000g at 4°C for 15 min.
The water phase was transferred to a new tube, and RNAwas precipitated with
isopropanol. The pellets were washed with 75% ethanol, air dried at room
temperature, and dissolved in RNase-free water. DNA contamination was
removed by treatment with DNase I (Roche Diagnostics, Sweden) at 37°C for
4 h after the DNase I was inactivated by heating the samples at 75°C for 15 min.
Absence of DNA contamination in the RNA was confirmed by PCR with
primers for rat glyceraldehyde-3-phosphate dehydrogenase (NM_017008; tcc
ctc aag att gtc agc aa, cac cac ctt ctt gat gtc atc) and RNA concentration was
determined using a Nanodrop ND-1000 Spectrophotometer (NanoDrop
Technologies, DE, USA). cDNA was synthesized with MMLV reverse
transcriptase (GE, Sweden), using random hexamers according to the
manufacturers’ instructions. The quality of the cDNA was tested by PCR as
described above.
Primer design and evaluation
All primers were designed with Beacon Designer v4.0 (Premier Biosoft,
USA): primers for rat housekeeping genes, histone 3 (H3; NM_053985; att cgc
aag ctc ccc ttt cag, tgg aag cgc agg tct gtt ttg), ribosomal protein L19 (RPL19;
NM:031103; tcg cca atg cca act ctc gtc, agc ccg gga atg gac agt cac) and rat SLC
genes, Slc25a8 (UCP2) (ggc ggt ggt cgg aga tac, ggc aag gga ggt cgt ctg);
Slc25a33 (cgg gaa gaa ggcagcaag, gta ggt gga cag gac aat gg); Slc25a37 (cag
tca gcc ctc agt tgt atc, ggt gat gaa gtg gat aga ttgg); Slc25a40 (aat gat aag ccc gtt
aga attg, gga aat cca acc gtc ttc ag); Slc25a41 (agg aat ttc ttc tac ggt gtgc, atg gga
ttg atg agt gtc tgg); Slc25a42 (cgg ctc ctc tac ttc acc tac, gaa ctg gat ggc tgc gta
ag); Slc25a43 (tct cgg ctg gct ctc ttc, tca cag tgt caa agg gaa atg); Slc25a44 (cag
agt aac aca gtc aaa tcac, ggg aga caa cat caa tggg); Slc25a45 (gca gcc tcc atc ttg
aaag, tga caa agt aca ttc cca acg); Slc25a46 (agc cac cta gcc gag agc, tcc ttg aat atg
aag acg atgc).
Quantitative real-time PCR
The cDNAwas analyzed in quantitative real-time PCR with a MyiQ thermal
cycler (Bio-Rad Laboratories, Sweden). Each real-time PCR with a total volume
of 20 μl contained cDNA synthesized from 25 ng of total RNA, 0.25 μM each
primer, 20 mM Tris/HCl (pH 8.4), 50 mM KCl, 4 mM MgCl2, 0.2 mM dNTP,
SYBR Green (1:50 000). Real-time PCR was performed with 0.02 u/μl Taq
DNA polymerase (Invitrogen, Sweden) under the following conditions: initial
denaturation for 3 min at 95°C, followed by 50 cycles of 15 s at 95°C, 15 s at 54–
61°C (optimal annealing temperature), and 30 s at 72°C. This was followed by
84 cycles of 10 s at 55°C (increased by 0.5°C per cycle). All real-time PCR
experiments were performed in duplicate and repeated twice. A negative control
for each primer pair and a positive control with 25 ng of rat genomic DNAwas
included on each plate.
Data analysis and relative expression calculations
The MyiQ software v 1.04 (Bio-Rad Laboratories, Sweden) was used to
analyze real-time PCR data and derive threshold cycle (Ct) values. Melting
curves were analyzed to confirm that only one product was amplified and that it
was significantly shifted compared to the melting curve for the negative control.
The sample Ct values were analyzed further if the difference between those and
the negative control was greater than 2; otherwise, the transcript was considered
not to be expressed.
LinRegPCR [25] was used to calculate PCR efficiencies for each sample.
After that Grubbs’ test (GraphPad, USA) was applied to exclude outliers and
calculate average PCR efficiency for each primer pair. The delta Ct method [26]
was used to transform Ct values into relative quantities with standard deviations
and the highest expression was normalized to 1. After that all values in each data
set were divided by the relative quantity for genomic DNA. The GeNorm
software [27] was used on the two housekeeping genes to calculate normalization
factors for every tissue to compensate for differences in cDNA amount.
789T. Haitina et al. / Genomics 88 (2006) 779–790Thereafter the normalized quantities were calculated and compared to genomic
DNA, which was set to 100%.
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